Comments
Sanofi, Novo, Lilly shape up for big insulin fight
30.05.2012. | LONDON (Reuters) - Competition is ramping up in the multibillion-dollar market for long-lasting insulins, with Novo Nordisk and Eli Lilly lining up new products that could trump Sanofi's top-seller Lantus....
